Bristol Myers Squibb
Company ● Covered in 2 stories + Follow ✴ AI Graph Claim this company LinkedIn
Bristol Myers Squibb is tracked in TLDRocket’s company dataset. Explore the recorded developments, relationships and supporting evidence below. Coverage reflects our monitored sources and may be incomplete.
Signals
1 story (new)
Media momentum
As of 1 Nov 2026 · Visible stories in the last 30 days, compared with the 30 days before.
2 sources
Source diversity
As of 1 Nov 2026 · Distinct publications behind this entity's visible coverage.
—
Release activity
As of 1 Nov 2026 · Model, product and open-source release events in the last 90 days whose coverage involves this entity.
—
Funding signals
As of 1 Nov 2026 · Funding and acquisition events in the last 90 days whose coverage involves this entity.
Jul 2026 → Oct 2026
Coverage span
As of 1 Nov 2026 · First to most recent month of TLDRocket coverage of this entity.
Management records
updated 5 Aug 2026Observed in public listings; this is not a verified current management roster.
- Chris Boerner Chair & CEO
- Chris Shibutani Executive Vice President, Chief Strategy Officer
- Cari Gallman Executive Vice President, General Counsel and Chief Policy Officer
- Cristian Massacesi Executive Vice President, Chief Medical Officer and Head of Development
- Amanda Poole EVP, Chief People Officer
- Adam Lenkowsky Executive Vice President, Chief Commercialization Officer
- Karin Shanahan Executive Vice President, Chief Supply Chain & Operations Officer
- Greg Meyers EVP, Chief Digital & Technology Officer, Member of Executive Committee
- Lynelle Hoch President, Cell Therapy Organization
- Mohit Dhingra Managing Director
- David Elkins Executive Vice President and Chief Financial Officer, Head of Global Business Operations
- Robert Plenge Executive Vice President, Chief Research Officer, Head of Research
+ 17 more tracked
Latest developments
October 2026
Funding: Bristol Myers Squibb & Pathos AI Funding
July 2026
Product launch: AMD & Anthropic Product launch
Relationships
Products & technology
- Deploys NVIDIA Vera Rubin · 1 source
Investment & ownership
- Invests in Pathos AI · 1 source